Literature DB >> 19664909

Antidepressive behaviors induced byenriched environment might be modulated by glucocorticoid levels.

Zhiwei Xu1, Bing Hou, Youzhi Zhang, Yan Gao, Yonghong Wu, Shifu Zhao, Chenggang Zhang.   

Abstract

Exposure to enriched environment (EE) can influence expression of depression symptoms, however, the underlying mechanism has not been established, although neurogenesis was probably involved. It has been reported that EE stimulates glucocorticoids release. However, the role of corticosterone (CORT) in effects of EE is still unknown. To address these issues, we examined depression-like behaviors of the animals exposed to EE with low dose CORT supplement following bilateral adrenalectomy (ADX+CORT). Two months after housing, tail suspension test and forced swim test were used to assess depression-related behavior of mice. Serum CORT levels were measured by radio-immunoassay. Signals of DNA synthesis marker bromodeoxyuridine and immature neuronal marker doublecortin were measured by immunohistochemistry. Results showed that EE significantly decreased immobility time of the mice in both the tail suspension test and forced swim test, showing distinctive antidepressive behaviors. Exposure to EE also increased serum CORT level, and prevention of this increase with ADX+CORT eliminated the decrease of immobility time of the animals. Both the mice exposed to EE and those receiving ADX+CORT treatment showed enhanced newly born cells and immature granule neurons in the hippocampus. Taken together, our data suggest that glucocorticoids elevation is required for antidepressive behaviors of EE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19664909     DOI: 10.1016/j.euroneuro.2009.07.004

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  8 in total

1.  Differential impact of a complex environment on positive affect in an animal model of individual differences in emotionality.

Authors:  J A Perez-Sepulveda; S B Flagel; M J Garcia-Fuster; R J Slusky; J W Aldridge; S Watson; H Akil
Journal:  Neuroscience       Date:  2013-06-24       Impact factor: 3.590

2.  Histochemical mapping of hnRNP A2/B1 in rat brain after ischemia-reperfusion insults.

Authors:  Yichen Liu; Yan Gao; Yan Wu; Yonghong Wu; Hangyan Wang; Chenggang Zhang
Journal:  J Histochem Cytochem       Date:  2010-04-26       Impact factor: 2.479

3.  Repeated swim impairs serotonin clearance via a corticosterone-sensitive mechanism: organic cation transporter 3, the smoking gun.

Authors:  Nicole Baganz; Rebecca Horton; Kathryn Martin; Andrew Holmes; Lynette C Daws
Journal:  J Neurosci       Date:  2010-11-10       Impact factor: 6.167

4.  Synergistic effects of combined therapy with transcranial photobiomodulation and enriched environment on depressive- and anxiety-like behaviors in a mice model of noise stress.

Authors:  Javad Mahmoudi; Seyed Hossein Rasta; Narmin Farazi; Saeed Sadigh-Eteghad; Fereshteh Farajdokht
Journal:  Lasers Med Sci       Date:  2021-08-25       Impact factor: 3.161

5.  Dynamic expression pattern of neuro-oncological ventral antigen 1 (Nova1) in the rat brain after focal cerebral ischemia/reperfusion insults.

Authors:  Hualing Li; Changqing Sun; Yu Wang; Yuxiao Gao; Yichen Liu; Yan Gao; Xu Li; Chenggang Zhang
Journal:  J Histochem Cytochem       Date:  2012-10-05       Impact factor: 2.479

6.  Enriched environment treatment reverses depression-like behavior and restores reduced hippocampal neurogenesis and protein levels of brain-derived neurotrophic factor in mice lacking its expression through promoter IV.

Authors:  S Jha; B Dong; K Sakata
Journal:  Transl Psychiatry       Date:  2011-09-13       Impact factor: 6.222

7.  Organic Cation Transporters in Psychiatric Disorders.

Authors:  Lynette C Daws
Journal:  Handb Exp Pharmacol       Date:  2021

Review 8.  Proteomics, metabolomics, and protein interactomics in the characterization of the molecular features of major depressive disorder.

Authors:  Daniel Martins-de-Souza
Journal:  Dialogues Clin Neurosci       Date:  2014-03       Impact factor: 5.986

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.